 |
 |
|
|
RESÚMENES AGOSTO 2006 |
Basic Neuroscience
& Pharmacology
(Haga un click en la información del journal
para acceder al resúmen)
Serotonin
Transporter Binding in Bipolar Disorder Assessed using [11C]DASB and Positron Emission Tomography
Dara M. Cannon, Masanori Ichise, Stephen J. Fromm, Allison C. Nugent, Denise Rollis, Shilpa K. Gandhi, Jacqueline M. Klaver, Dennis S. Charneyc
, Husseini K. Manji and Wayne C. DrevetsBiological Psychiatry. Volume 60, Issue 3, 1 August 2006, Pages 207-217
CNS
& Neurological Disorders - Drug Targets, Volume 5, Number 4, August
2006, pp. 445-452(8)
Hauger, Richard
L.;
CNS
& Neurological Disorders - Drug Targets, Volume 5, Number 4, August
2006, pp. 453-479(27)
Australian and New Zealand Journal of Psychiatry. Volume 40 Page 725
- September 2006
Cortical–subcortical re-entrant circuits and recurrent behaviour
Australian and New
Zealand Journal of Psychiatry. Volume 40 Page 752 - September
2006
Clinical
correlates of DHEA associated with post-traumatic stress disorder
R. Yehuda, S.
R. Brand, J. A. Golier, R.-K. Yang
Acta Psychiatrica Scandinavica. Volume
114 Page 187 - September 2006
Neuroscience
Letters. Volume 404, Issue 3,
1 September 2006, Pages 358-362
Frames, Biases, and Rational
Decision-Making in the Human Brain
Benedetto De
Martino, Dharshan Kumaran, Ben Seymour, Raymond J. Dolan
Science 4 August 2006: Vol. 313. no. 5787,
pp. 684 - 687
Neuroscience
Letters. Volume 405, Issues
1-2, 11 September 2006, Pages 79-83 Antidepressant-like activity of selective serotonin
reuptake inhibitors combined with a NK1 receptor antagonist in the mouse forced
swimming test F. Chenu, B.P. Guiard,
M. Bourin and A.M. Gardier Behavioural Brain
Research.
Volume 172, Issue 2, 25 September 2006,
Pages 256-263 Effects of medial amygdala
inactivation on a panic-related behavior Karina Costa Paes Herdade,
Christiana Villela de Andrade Strauss, Hélio Zangrossi Júnior and Milena de Barros Viana Behavioural Brain
Research.
Volume 172, Issue 2, 25 September 2006,
Pages 316-323 Clozapine and haloperidol differentially regulate dendritic spine formation and synaptogenesis
in rat hippocampal neurons H.M. Critchlow, P.R. Maycox, J.N. Skepper and O. Krylova Molecular and Cellular Neuroscience. Volume 32, Issue 4, August 2006, Pages 356-365
Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein Jun-Sheng Wang, Hao-Jie Zhu,
John S. Markowitz, Jennifer L. Donovan and
C. Lindsay DeVane Psychopharmacology 2006; Volume 187, Number 4: 415 - 423
Comparison of pramipexole and amisulpride on
alertness, autonomic and endocrine functions in healthy volunteers E. R. Samuels, R. H. Hou,
R. W. Langley, E. Szabadi and
C. M. Bradshaw Psychopharmacology 2006; Volume 187, Number 4: 498 - 510 Effects of the
Serotonin Type 2A, 3A and 3B Receptor and the Serotonin Transporter Genes on Paroxetine and Fluvoxamine
Efficacy and Adverse Drug Reactions in Depressed Japanese Patients Neurocircuitry Models of Posttraumatic Stress Disorder and
Extinction: Human Neuroimaging Research—Past,
Present, and Future Scott L. Rauch, Lisa
M. Shin and Elizabeth A. Phelps Biological Psychiatry. Volume 60, Issue 4, 15 August 2006, Pages 376-382 Lithium increases nerve growth factor levels in the rat hippocampus in an
animal model of mania Frey, Benicio N; Andreazza, Ana C;
Rosa, Adriane R; Martins, Marcio R; Valvassori, Samira S; Reus, Gislaine
Z; Hatch, John P; Quevedo, Joao; Kapczinski,
Flavio Behavioural Pharmacology. 17(4):311-318, June 2006 Dissociation between In Vivo Occupancy and Functional
Antagonism of Dopamine D2 Receptors: Comparing Aripiprazole
to Other Antipsychotics in Animal Models Sridhar Natesan, Greg
E Reckless, José N Nobrega, Paul
J Fletcher and Shitij Kapur Neuropsychopharmacology (2006) 31, 1854–1863 Multidose
Risperidone Treatment Evaluated in a Rodent Model of Tardive Dyskinesia Xue-Min Gao, Thomas Cooper, Raymond F Suckow and Carol A Tamminga Neuropsychopharmacology (2006) 31, 1864–1868 Antipsychotic-Like vs Cataleptogenic Actions in Mice of Novel Antipsychotics
Having D2 Antagonist and 5-HT1A Agonist Properties Laurent Bardin, Mark
S Kleven, Catherine Barret-Grévoz,
Ronan Depoortère and Adrian Newman-Tancredi Neuropsychopharmacology (2006) 31, 1869–1879 Chronic Olanzapine
Treatment Causes Differential Expression of Genes in Frontal Cortex of Rats as
Revealed by DNA Microarray Technique S Hossein Fatemi, Teri J Reutiman,
Timothy D Folsom, Christopher Bell, Lisa Nos,
Peter Fried, David A Pearce, Sushmita Singh,
David P Siderovski, Francis S Willard and Mitsunori Fukuda Neuropsychopharmacology (2006) 31, 1888–1899 Occupancy of Striatal
and Extrastriatal Dopamine D2 Receptors by
Clozapine and Quetiapine Robert M Kessler, M Sib Ansari,
Patrizia Riccardi, Rui Li, Karuna Jayathilake, Benoit Dawant
and Herbert Y Meltzer Neuropsychopharmacology (2006) 31, 1991–2001 Plasma copper, iron,
ceruloplasmin and ferroxidase
activity in schizophrenia Teri L. Wolf, Joan Kotun and James H. Meador-Woodruff Schizophrenia Research. Volume 86, Issues 1-3, September 2006, Pages 167-171 Electrical brain
activity and response to olanzapine in schizophrenia:
A study with LORETA images of P300 Tomiki Sumiyoshi, Yuko Higuchi, Yasuhiro Kawasaki, Mie
Matsui, Kanade Kato, Hiromi Yuuki,
Hirofumi Arai and Masayoshi Kurachi ABC drug transporter at the blood–brain barrier. Effects on drug
metabolism and drug response
Martin Ebinger and Manfred Uhr Transgenic
brain-derived neurotrophic factor expression causes
both anxiogenic and antidepressant effects Arvind Govindarajan, B. S. Shankaranarayana
Rao, Deepti Nair, Mimi
Trinh, Nadya Mawjee, Susumu
Tonegawa, and Sumantra Chattarji PNAS | August 29, 2006
| vol. 103 | no. 35 | 13208-13213 Metabolic Profiling of CSF: Evidence That Early
Intervention May Impact on Disease Progression and Outcome in Schizophrenia. Holmes E, Tsang TM, Huang JTJ, Leweke
FM, Koethe D, et al. Effects of
lithium and valproate on amphetamine-induced
oxidative stress generation in an animal model of mania Benicio N. Frey, Samira S. Valvassori, Gislaine Z. Réus, Márcio R. Martins,
Fabrícia C. Petronilho,
Katrine Bardini,
Felipe Dal-Pizzol, Flávio Kapczinski, João Quevedo J Psychiatry
Neurosci 2006;31(5):326-32 Fluoxetine-induced alterations
in human platelet serotonin
transporter expression: serotonin transporter polymorphism effects Karley Y. Little, Lian
Zhang, Edwin Cook J Psychiatry
Neurosci 2006;31(5):333-9 Inhibition of N-methyl-D-aspartate
receptor function appears to be one of the common actions for antidepressants Yun-Feng Li, You-Zhi Zhang, Yan-Qin Liu, Heng-Lin Wang, Jiang-Bei Cao,
Ting-Ting Guan, Zhi-Pu Luo Journal of Psychopharmacology, Vol. 20, No. 5, 629-635
(2006) Selective increases in the cytokine, TNF G. J. Paterson, Y. Ohashi,
G. P. Reynolds, J. A. Pratt, B. J. Morris Journal of Psychopharmacology, Vol. 20, No. 5, 636-642
(2006) Plasma oxytocin levels in
depression and their correlation with the temperament dimension of reward
dependence Caroline J. Bell, Helen Nicholson, Roger T. Mulder, Sue E. Luty, Peter R.
Joyce Journal of Psychopharmacology, Vol. 20, No. 5, 656-660
(2006)
Masaki
Kato, Tsuyoshi Fukuda, Masataka Wakeno,
Kazuhiro Fukuda, Gaku Okugawa,
Yuka Ikenaga, Megumi Yamashita, Yoshiteru
Takekita, Kenji Nobuhara,
Junichi Azuma, Toshihiko Kinoshita
Neuropsychobiology 2006;53:186-195
,
in the prefrontal cortex of PCP-treated rats and human schizophrenic subjects:
influence of antipsychotic drugs